TherapeuticsMD, a parent company of vitaMedMD, has filed additional patent applications for its prescription products to treat menopausal symptoms and related conditions.
Subscribe to our email newsletter
The patent applications concern its proprietary formulation technologies for its products TX12001HR, TX12002HR and TX12003HR.
TherapeuticsMD CEO Robert Finizio said, "The submission of these patents marks a new platform for Therapeutics’ expansion in the women’s health market."
The company expects to begin trials for the prescription products shortly and hence aims to seek FDA approval under a new drug approval for the products as early as 2013 and as late as 2015.